tiprankstipranks
Trending News
More News >
Essity AB (SE:ESSITY.B)
:ESSITY.B

Essity AB (ESSITY.B) AI Stock Analysis

Compare
4 Followers

Top Page

SE:ESSITY.B

Essity AB

(ESSITY.B)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
kr312.00
▲(18.09% Upside)
Action:DowngradedDate:01/26/26
The score is driven by solid fundamentals (improving margins, stronger balance sheet, consistently positive free cash flow) and a constructive earnings outlook emphasizing savings, reinvestment for growth, and shareholder returns. These positives are tempered by weak technical momentum and lingering volume/price headwinds in key consumer categories.
Positive Factors
Margin expansion and profitability recovery
Sustained margin expansion to 14.1% signals structural improvement in cost base and pricing execution. Higher operating margins support durable free cash flow, fund buybacks/dividends and reinvestment into A&P and innovation, improving resilience versus cyclical revenue swings.
Improved leverage and consistent cash generation
Marked deleveraging and net debt/EBITDA near 1.0 plus recurring positive free cash flow increase financial flexibility. This stronger balance-sheet footing supports strategic M&A, ongoing buybacks and higher dividend policy while reducing refinancing and liquidity risk.
Strategic M&A, share gains and product innovation
The Edgewell deal and consistent market-share gains materially scale U.S. personal-care exposure and raise branded mix. Coupled with product upgrades and innovation in Health & Medical, this strengthens structural growth avenues and margin uplift potential across core categories.
Negative Factors
Choppy revenue and category volume declines
Persistent revenue softness and category volume declines (notably Baby Care and Consumer Tissue) indicate structural demand pressures. Reduced volumes can erode scale, raise per-unit costs and limit the ability to sustain pricing, constraining long-term top-line recovery.
Price/mix headwinds and promotional pressure
Negative price/mix and higher promotional intensity, plus lost private-label contracts, weaken pricing power. If sustained, this compresses margins and forces reinvestment in A&P or promotions to defend share, limiting net margin durability despite cost savings.
Unusual 2025 debt reporting reduces comparability
Anomalous 2025 debt reporting complicates trend analysis of leverage and liquidity. This opacity raises uncertainty about true financial flexibility and capital structure risk, making medium-term assessment of funding capacity and covenant exposure less reliable.

Essity AB (ESSITY.B) vs. iShares MSCI Sweden ETF (EWD)

Essity AB Business Overview & Revenue Model

Company DescriptionEssity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
How the Company Makes MoneyEssity generates revenue through the sale of its hygiene and health products across various consumer and professional segments. The company's primary revenue streams include the sale of consumer goods, which encompass personal care products like diapers and feminine hygiene items, as well as professional hygiene products for businesses, such as washroom hygiene solutions and industrial wipes. Additionally, Essity benefits from strong brand recognition, which contributes to customer loyalty and repeat purchases. The company has established significant partnerships with retailers and distributors globally, ensuring a widespread presence in various markets. Factors such as innovation in product development, a focus on sustainability, and expanding into emerging markets further enhance its earning potential.

Essity AB Earnings Call Summary

Earnings Call Date:Jan 22, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 23, 2026
Earnings Call Sentiment Positive
The call presented a predominantly constructive operational and financial picture: strong margin expansion, substantial COGS tailwinds and realized cost savings, solid cash flow and balance-sheet metrics (net debt/EBITDA ~1.0), successful strategic M&A and clear market-share gains and product innovation momentum—particularly in Health & Medical, Incontinence and premium Professional Hygiene. Offsetting these positives are continuing end-market headwinds in Baby and Consumer Tissue (volume declines of ~4% and ~2% respectively), negative price/mix in the quarter (~-0.9%), some one-off rebate impacts (Latin America Feminine), lost private-label contracts and the near-term costs of the restructuring program. Management’s messaging emphasizes agility, reinvestment of savings into A&P to drive volume, a disciplined M&A stance, and confidence in returning to stronger profitable volume growth in 2026. On balance, the positive margin, cash and strategic momentum outweigh the category-specific volume challenges and temporary pricing effects.
Q4-2025 Updates
Positive Updates
Improved Profitability and Margins
Operating margin for 2025 of 14.1% (second-highest historic level outside pandemic); gross profit margin improved ~180 basis points in Q4 versus prior year; margin improvements reported across all three business areas.
Full-Year Organic Sales Growth
Organic sales growth for 2025 of +0.9% despite challenging market conditions and weak consumer sentiment.
Strong Cash Flow and Balance Sheet
Q4 delivered strong operating cash surplus and working capital improvements (inventory days down); net debt/EBITDA ~1.0 at year-end; net cash flow strong.
COGS Tailwind and Cost Savings Realized
Q4 COGS tailwind of SEK 749 million (approx. two-thirds from raw materials, remainder primarily energy); realized COGS savings just above SEK 500 million within the SEK 500m–1bn target range.
Shareholder Returns and Capital Allocation
Share buyback program (SEK 3.0bn) ~80% completed: 9.2 million shares repurchased for SEK 2.4bn; proposed dividend increase to SEK 8.75 (up SEK 0.50, ~+6%).
Strategic Acquisition to Expand U.S. Personal Care
Acquisition of Edgewell Feminine Care business in North America (brands Carefree, Stayfree, Playtex) more than doubles Personal Care sales in the U.S., aligning with focus on high-yielding categories.
Market Share Gains and Product Superiority
Branded market shares strengthened in >65% of the business and in 80% of Feminine Care; Mexico Feminine Care market share reached 62%; record level of product superiority and increased share of sales from innovations.
Health & Medical Momentum
Positive organic sales growth in Health & Medical; Medical business grew for the 19th consecutive quarter across all three therapy areas, with strong performance in Wound Care and Incontinence Care.
Sustainability Recognition
Awarded EcoVadis Platinum (top 1% globally) and placed on CDP A list, reinforcing sustainability credentials especially relevant to health-care customers.
Innovation and Portfolio Upgrades
Key product actions: upgraded TENA Flex belted product, relaunched Cutimed Siltec Sorbact with a brand campaign, new SmartPROTECT core tech for ultra-thin pads in Latin America, PeakServe sensor dispenser launch and center-feed dispenser and refill innovations.
Negative Updates
Negative Organic Sales in Q4
Q4 reported negative organic sales growth driven by price declines (management lowered prices to pass on lower input costs) and slight volume decline versus the prior-year quarter.
Volume Weakness in Consumer Goods Categories
Group volume decline of approximately -0.2% year/period; Baby Care volumes down ~4% (impact from lower birth rates and fierce competition); Consumer Tissue volumes down ~2%; Professional Hygiene volumes down ~0.5%.
Price/Mix Pressure
Price and mix headwind around -0.9% reported (contributing to negative organic sales in the quarter), with selective price reductions and promotional activity affecting reported pricing.
Lost Private Label Contracts and Promotional Pressure
Consumer Tissue faced contract losses to private labels due to pricing, leading to volume and revenue pressure; high promotional intensity in Consumer Tissue remains a challenge.
One-Off Latin America Impact in Feminine
A one-time increase in customer rebates in Latin America reduced Q4 Feminine sales and pricing metrics; management expects this to be temporary and to normalize in the next quarter.
Market Weakness and Funding Cuts in Select Markets
Weak consumer sentiment and funding cuts in selected markets (example: Indonesia) are pressuring some end markets—particularly HoReCa and parts of retail—limiting topline momentum.
Near-Term Cost of Restructuring Program
Cost-saving program targeting SEK 1bn run-rate by end-2026 will incur restructuring charges of approximately SEK 1.1bn, with most savings expected to be realized later in the year.
Q4 Comparable Toughness and Seasonal Uncertainty
Q4 2024 was a strong comparator, making YoY Q4 comparisons more difficult; seasonality typically sees Q1 volumes lower than Q4, creating near-term uncertainty in volume phasing.
Company Guidance
Guidance in the call was that Q1 2026 should see slightly lower COGS (partly from savings and favourable raw‑material FX) but slightly higher SG&A versus Q1 2025, driven primarily by increased A&P to fuel growth; for the full year management expects CapEx of SEK 8.0–8.5 billion, corporate costs of about SEK 1.3 billion, a structural tax rate of 25–26%, and reiterates COGS‑savings guidance of SEK 500 million–1 billion. They plan an SG&A cost‑savings program targeting a SEK 1.0 billion run‑rate by end‑2026 (with restructuring charges of ~SEK 1.1 billion expected), will reinvest the majority of savings into growth, and noted a strong balance‑sheet position (net debt/EBITDA ≈ 1.0) while continuing the SEK 3.0 billion share buyback (≈ SEK 2.4 billion / 9.2 million shares, ~80% completed).

Essity AB Financial Statement Overview

Summary
Financials are solid overall: profitability recovered strongly from 2022 and margins are healthy, the balance sheet has improved with lower leverage, and free cash flow is consistently positive with a strong 2025 rebound. Offsetting factors are choppy/declining revenue, volatile net income, only moderate cash conversion versus earnings, and an unusual 2025 debt figure that reduces comparability.
Income Statement
71
Positive
Revenue has been choppy and recently declined (2025 revenue down ~2% after slight declines in 2023–2024). Profitability improved meaningfully from the 2022 trough, with stronger gross and operating margins and solid 2025 operating profit, but net profit was volatile (very strong in 2024, materially lower in 2025). Overall, margins are healthy for the sector, but the inconsistent top-line trend and earnings volatility keep the score from being higher.
Balance Sheet
78
Positive
Leverage has improved substantially over time, with debt-to-equity moving from ~1.0 (2021–2022) to ~0.50 in 2024 and reported as zero in 2025, alongside a large equity base. Returns on equity have remained solid across the period (high in 2024, still healthy in 2025). The main concern is the unusual 2025 debt figure versus prior years, which raises comparability/quality questions, but the overall balance sheet trajectory looks stronger and less risky than earlier years.
Cash Flow
66
Positive
Cash generation is solid, with positive free cash flow each year and a strong rebound in 2025 free cash flow (+32% year over year). However, cash conversion is only moderate: free cash flow is roughly half of net income in 2024–2025, and operating cash flow is a relatively small share of revenue (high teens to low 20s billions on ~140–156B revenue). The business is consistently cash-generative, but variability in free cash flow growth and only middling conversion versus earnings temper the score.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue138.49B145.55B147.15B156.17B121.87B
Gross Profit46.12B47.13B45.13B37.23B35.09B
EBITDA25.74B26.14B20.90B15.44B20.45B
Net Income12.66B20.89B9.55B5.57B8.62B
Balance Sheet
Total Assets167.12B185.28B202.99B210.60B175.05B
Cash, Cash Equivalents and Short-Term Investments9.75B15.62B5.19B4.50B4.09B
Total Debt38.63B43.78B60.98B71.52B56.83B
Total Liabilities81.08B96.54B123.59B134.04B106.54B
Stockholders Equity85.63B88.31B70.85B67.35B59.87B
Cash Flow
Free Cash Flow8.37B9.40B14.68B5.92B7.31B
Operating Cash Flow15.46B16.80B21.57B12.87B14.67B
Investing Cash Flow-3.22B9.41B-7.11B-14.50B-12.13B
Financing Cash Flow-14.40B-22.34B-11.55B1.81B-3.81B

Essity AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price264.20
Price Trends
50DMA
270.84
Negative
100DMA
265.90
Positive
200DMA
261.38
Positive
Market Momentum
MACD
1.85
Positive
RSI
37.67
Neutral
STOCH
5.07
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ESSITY.B, the sentiment is Negative. The current price of 264.2 is below the 20-day moving average (MA) of 281.23, below the 50-day MA of 270.84, and above the 200-day MA of 261.38, indicating a neutral trend. The MACD of 1.85 indicates Positive momentum. The RSI at 37.67 is Neutral, neither overbought nor oversold. The STOCH value of 5.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ESSITY.B.

Essity AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
kr5.53B17.5151.65%2.54%48.79%38.02%
67
Neutral
kr186.20B14.4414.26%3.13%-1.91%-40.37%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
kr4.49B15.859.65%4.83%3.79%39.15%
47
Neutral
kr113.54M22.145.40%8.54%-4.76%
42
Neutral
kr14.53M-0.73-354.88%-15.74%44.98%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:ESSITY.B
Essity AB
266.90
-27.28
-9.27%
SE:ZZ.B
Zinzino AB
152.00
8.62
6.01%
SE:DUNI
Duni AB
95.50
-0.46
-0.48%
SE:LCLEAN
LifeClean International AB
0.05
-0.19
-78.37%
SE:CLEM
Clemondo Group AB
8.75
1.30
17.45%

Essity AB Corporate Events

Essity Advances SEK 3bn Share Buyback, Lifting Treasury Stock to 11.2 Million Shares
Feb 23, 2026

Essity has continued to execute on its SEK 3bn share buyback program, repurchasing 63,292 Class B shares on Nasdaq Stockholm during week eight of 2026 for a total consideration of about SEK 18m. The purchases, carried out by BofA Securities Europe on Essity’s behalf, were financed from operating cash flow after dividends and form part of the company’s ambition to make buybacks a recurring element of its capital allocation strategy.

Since the start of the program in April 2025, Essity has bought back more than 10.4 million Class B shares for roughly SEK 2.7bn, increasing its treasury stock to 11.2 million Class B shares as of February 20, 2026. With a total share count of just over 693 million, the ongoing buybacks are expected to support capital efficiency and may enhance value for existing shareholders by gradually reducing the float of Essity’s Class B shares.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK314.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity outlines procedures for 2026 Annual General Meeting participation
Feb 19, 2026

Essity has convened its 2026 Annual General Meeting for 26 March at the Stockholm Waterfront Congress Centre, offering shareholders the option to participate in person, by proxy, or through advance postal voting. To exercise their voting rights, shareholders must be registered with Euroclear Sweden AB by 18 March 2026 and must either notify the company of in-person or proxy attendance or submit a valid advance voting form by 20 March 2026.

The company sets out detailed procedures for nominee-registered shareholders to obtain temporary voting rights registration, as well as documentation requirements for proxies and legal entities. By formalizing multiple participation channels and emphasizing deadlines and documentation, Essity aims to facilitate broad shareholder engagement and ensure orderly governance at its 2026 AGM.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK311.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity to Showcase Growth Strategy and Sustainable Production at May Capital Markets Day
Feb 17, 2026

Essity will host a Capital Markets Day on May 7, 2026, at its Gothenburg office, where President and CEO Ulrika Kolsrud and the executive team will outline the company’s strategy for profitable growth and detail value-creation initiatives across its business areas in relation to financial targets. The event, aimed primarily at institutional investors, analysts and media, includes presentations, an R&D tour, innovation demonstrations, optional visits to low‑carbon tissue and incontinence product facilities in western Sweden, and will be livestreamed and available on demand, underscoring Essity’s focus on innovation, sustainability and operational efficiency.

The program features a guided tour of Essity’s Gothenburg R&D operations, showcasing innovations across its product categories and providing multiple opportunities for questions and discussion. In the afternoon, participants may visit either the Lilla Edet tissue mill, highlighted as the world’s first large-scale tissue facility with production free from fossil CO₂ emissions, or the Falkenberg site, an innovation-driven plant for incontinence products and baby diapers that plays a key role in Essity’s European supply chain.

By opening its production sites and R&D centers to the financial community, Essity aims to demonstrate the practical execution of its growth and sustainability strategies while reinforcing transparency with capital markets stakeholders. The focus on fossil-free production at Lilla Edet and agile, innovation-centered manufacturing at Falkenberg is likely to bolster the company’s positioning as a sustainability leader in hygiene and health and may support investor confidence in its ability to meet long-term financial and environmental objectives.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK314.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Advances SEK 3bn Share Buyback With New Class B Repurchases
Feb 16, 2026

Essity has continued executing its SEK 3bn share buyback program, repurchasing 65,565 Class B shares on Nasdaq Stockholm during the week of February 9–13, 2026, at a weighted average price of SEK 279.44 per share. These transactions, carried out by BofA Securities Europe on Essity’s behalf and financed from post‑dividend operating cash flow, signal the company’s intent to make buybacks a recurring element of capital allocation.

Following these purchases, Essity’s treasury stock rose to 11,174,883 Class B shares out of a total 693,054,489 shares outstanding, while cumulative repurchases under the program reached 10,392,383 shares for roughly SEK 2.69bn. The ongoing reduction in free‑float equity may support earnings per share and underscores management’s confidence in Essity’s financial position, with potential implications for shareholder returns and market valuation.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK314.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Advances SEK 3bn Share Buyback With New Week of B‑Share Purchases
Feb 9, 2026

Essity has continued to execute on its capital allocation strategy by repurchasing 69,537 Class B shares during the week of February 2–6, 2026, as part of its previously announced SEK 3bn share buyback program. The transactions, carried out on Nasdaq Stockholm by BofA Securities Europe SA and financed from post‑dividend operating cash flow, lift the company’s treasury holding to 11.1 million Class B shares out of a total 693.1 million shares, underscoring management’s commitment to ongoing share buybacks as a recurring tool for returning capital to shareholders.

By steadily acquiring shares at a weighted average price of about SEK 270 during the period, Essity has brought total repurchases under the program to more than 10.3 million Class B shares at a cost of roughly SEK 2.67bn. The gradual build‑up of treasury stock may support earnings per share and capital structure optimization ahead of the 2026 annual meeting, signalling confidence in the company’s long‑term prospects and potentially enhancing value for existing investors.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Closes USD 340m Deal for Edgewell’s Feminine Care Brands to Bolster US Presence
Feb 2, 2026

Essity has completed its USD 340m acquisition of Edgewell Personal Care’s feminine care business, securing the Carefree, Stayfree and o.b. brands in North America along with global feminine care rights to the Playtex brand, plus a production facility in Dover, Delaware. The deal, which will be consolidated into Essity’s accounts from 2 February 2026, significantly expands the company’s portfolio of liners, pads and tampons in the US, Canada and the Caribbean and aligns with its strategy to concentrate on high-margin categories and strengthen its position in the US, the world’s largest hygiene market, reinforcing its fast-growing feminine care franchise that already includes brands such as Libresse, Bodyform, Nana, Saba, Libra, Nosotras, Knix and Modibodi.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Advances SEK 3bn Share Buyback Program With New Class B Repurchases
Feb 2, 2026

Essity has continued executing its SEK 3bn share buyback program, repurchasing 170,916 Class B shares on Nasdaq Stockholm between January 26 and 30, 2026, for a total of about SEK 43.8m at an average price of SEK 256.41 per share. The purchases, carried out by BofA Securities Europe on Essity’s behalf and financed with cash flow from ongoing operations after the ordinary dividend, lift the company’s treasury stock to 11,039,781 Class B shares out of 693,054,489 total shares, underscoring Essity’s intention to make buybacks a recurring component of its capital allocation strategy and potentially enhancing shareholder value by reducing the free float over time.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Adjusts Voting Structure After Conversion of Class A Shares to Class B
Jan 30, 2026

Essity has disclosed a change in its share capital structure following the conversion of 1,000,000 Class A shares into Class B shares at the request of shareholders, a move that reduces the total number of votes in the company. After the conversion, Essity’s total number of votes is 1,207,860,411, while the total number of registered shares remains 693,054,489, now comprising 57,200,658 Class A shares and 635,853,831 Class B shares, a shift that slightly dilutes voting concentration among high-vote shares but leaves overall share count unchanged.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK270.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Secures EUR 400m EIB Loan to Boost Innovation and Sustainability
Jan 29, 2026

Essity has secured a seven-year EUR 400 million loan from the European Investment Bank on favorable terms to finance research, development and innovation across all its business areas. The funding is aimed at strengthening Essity’s innovation capabilities, supporting value-enhancing upgrades and breakthrough product launches that combine sustainability and performance, reinforcing the company’s competitive position while contributing to Europe’s technological leadership in hygiene and health and advancing the green transition and circular economy objectives.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK270.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Expands Share Buyback, Lifts Treasury Stock to Nearly 10.9 Million B Shares
Jan 26, 2026

Essity has repurchased 725,349 of its own Class B shares on Nasdaq Stockholm between January 19 and 23, 2026, as part of a SEK 3bn share buyback program running until the 2026 Annual General Meeting. The buybacks, executed by BofA Securities Europe SA and financed from operating cash flow after dividends, bring the total repurchased under the program to 10,086,365 shares and raise Essity’s treasury holding to 10,868,865 Class B shares, signaling a continued commitment to returning capital to shareholders and embedding buybacks as a recurring element of its capital allocation strategy.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK280.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Wins CDP A List Recognition for Forest Leadership and Strong Climate Performance
Jan 22, 2026

Essity has been named to environmental non-profit CDP’s prestigious A List for its performance and transparency on forests and received an A- rating for climate, placing it among the top 4% of more than 22,000 companies assessed globally. The recognition underscores Essity’s strategy to integrate sustainability across its value chain, including its commitment to net-zero emissions by 2050, a 35% value-chain emissions reduction target by 2030, and strict certification and third-party Chain of Custody sourcing for all fresh and recycled wood-based fibers, strengthening its position as a sustainability leader in the hygiene and health sector.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Lifts Profitability and Dividend Despite Lower 2025 Sales
Jan 22, 2026

Essity ended 2025 with higher margins and profitability despite lower reported sales, as currency effects weighed on the top line but underlying demand and pricing remained resilient. In the fourth quarter, net sales fell 8.2% to SEK 34.7bn and organic sales declined 1.1%, yet EBITA excluding items affecting comparability rose 3% and the margin improved to 14.7%, driving an 11% increase in profit for the period. For the full year, net sales decreased 4.8% to SEK 138.5bn, although net sales excluding currency translation effects increased and organic sales grew 0.9%, while EBITA was broadly flat and margins edged higher. Return on capital employed strengthened and earnings per share from continuing operations increased, and the board proposed a 6% dividend hike, signalling confidence in cash generation and balance sheet strength despite a sharp year-on-year decline in profit for total operations due to non-recurring effects in the prior year.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Sets Capital Markets Day to Showcase Growth Strategy and Targets
Jan 22, 2026

Essity has scheduled a Capital Markets Day for May 7, 2026, at its Gothenburg office, aimed at giving institutional investors, analysts and media a detailed update on its strategy and progress. President and CEO Ulrika Kolsrud and the executive management team will outline plans to drive profitable volume growth and accelerate the achievement of the company’s financial targets, with presentations available both on-site and online and optional visits to regional R&D and production facilities, underscoring Essity’s efforts to strengthen transparency and reinforce its positioning in the hygiene and health sector.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Expands Treasury Stock with Continued Share Buybacks in January 2026
Jan 19, 2026

Essity has continued to execute its ongoing share buyback program, repurchasing 66,186 Class B shares on Nasdaq Stockholm between 12 and 16 January 2026 for a total of about SEK 17.7m at an average price of SEK 267.31 per share. The purchases, conducted by BofA Securities Europe on Essity’s behalf and financed from operating cash flow after ordinary dividends, form part of a SEK 3bn buyback mandate running until the 2026 AGM, and lift the company’s treasury holding to 10,143,516 Class B shares out of a total 693,054,489 shares outstanding, underscoring its commitment to using recurring buybacks as a core element of capital allocation and potentially enhancing long-term shareholder value.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Steps Up SEK 3bn Share Buyback, Lifts Treasury Share Holding
Jan 12, 2026

Essity has continued executing its previously announced SEK 3bn share buyback program, repurchasing 57,798 Class B shares on Nasdaq Stockholm during the week of January 5–9, 2026, at a total transaction value of about SEK 15.1m. The buybacks, carried out by BofA Securities Europe SA and financed from operating cash flow after ordinary dividends, bring the total number of Class B shares repurchased under the program to 9,294,830 and increase Essity’s treasury holding to 10,077,330 Class B shares out of 693,054,489 shares outstanding, underscoring the company’s intention to make share repurchases a recurring element of its capital allocation strategy.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Lawsuit Over Bond Loans Dropped After Agreement With Funds
Jan 8, 2026

Essity has closed a legal dispute in the English courts after funds that had challenged the company over bond loans maturing in 2029, 2030 and 2031 chose to discontinue their lawsuit. The parties reached an agreement confirming that neither side has claims against the other arising from Essity’s sale of its shares in Vinda, and Essity emphasizes that it has not paid or otherwise compensated the funds and continues to view the action as unfounded, removing a potential legal overhang for bond investors and shareholders.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK290.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Advances SEK 3bn Share Buyback, Increases Treasury Shareholding
Jan 5, 2026

Essity has continued to execute its previously announced SEK 3 billion share buyback program, repurchasing 42,073 Class B shares on Nasdaq Stockholm between December 29, 2025 and January 2, 2026, at a weighted average price of SEK 263.67 and a total value of about SEK 11.1 million. The program, financed from post-dividend operating cash flow and intended as a recurring component of Essity’s capital allocation, has so far resulted in 9.24 million Class B shares being bought back, bringing the company’s treasury holding to just over 10 million Class B shares out of a total 693 million shares outstanding, a move that underscores Essity’s continued focus on shareholder returns and balance sheet discipline.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK253.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Reports Share Conversion That Marginally Reduces Voting Power Concentration
Dec 30, 2025

Essity has disclosed a change in its share structure following the conversion of 146,000 Class A shares into Class B shares at the request of shareholders. The move, which reduces the company’s total voting rights to 1,216,860,411 while keeping the overall number of registered shares unchanged at 693,054,489, reflects ongoing shareholder use of the company’s share-class conversion mechanism and marginally dilutes concentrated voting power among Class A holders, potentially supporting a broader base of investor influence over time.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK253.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Continues Share Buyback Program With Week 52 Class B Repurchases
Dec 29, 2025

Essity has continued execution of its SEK 3bn share buyback program, repurchasing 29,421 Class B shares on Nasdaq Stockholm during week 52 of 2025 at a total transaction value of about SEK 7.7m. The purchases, carried out by BofA Securities Europe SA and financed from operational cash flow after dividends, increase the company’s treasury stock of Class B shares to 9,977,459, signalling an ongoing commitment to shareholder returns and embedding share repurchases as a recurring element of Essity’s capital allocation strategy.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK253.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Steps Up SEK 3bn Share Buyback, Lifts Treasury Stock to Nearly 10 Million Shares
Dec 22, 2025

Essity has continued executing its SEK 3bn share buyback program, repurchasing 73,113 Class B shares on Nasdaq Stockholm during the week of December 15–19, 2025, at a total value of about SEK 19.4m and an average price of SEK 265.33 per share. The program, financed from operating cash flow after dividends and conducted under EU market regulations, has so far resulted in the buyback of more than 9.16 million Class B shares, bringing Essity’s treasury holding to 9.95 million Class B shares out of a total 693 million outstanding, underscoring the company’s commitment to ongoing shareholder returns as a recurring element of its capital allocation strategy.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK253.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity to Present Q4 and Full-Year 2025 Financial Report
Dec 17, 2025

Essity announced it will release its Q4 and full-year 2025 financial report on January 22, 2026. The report will be presented by President and CEO Ulrika Kolsrud and CFO Fredrik Rystedt via a live webcast and teleconference, providing stakeholders with insights into the company’s financial performance.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Continues Share Buyback Program
Dec 15, 2025

Essity announced the repurchase of 156,888 Class B shares as part of its SEK 3 billion buyback program, which runs until the 2026 Annual General Meeting. The buyback is financed by cash flow from operations and aims to be a recurring element of Essity’s capital allocation strategy, potentially impacting shareholder value and market perception.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Appoints Ilham Smaali as Chief Supply Chain Officer
Dec 12, 2025

Essity has appointed Ilham Smaali as the new Chief Supply Chain Officer, effective December 31, 2025. This appointment is part of Essity’s strategy to enhance its supply chain operations through a newly established function, Supply Chain Enablement, aimed at achieving economies of scale and standardizing processes. Smaali, who has been with Essity since 2023, brings extensive experience from her previous roles at Estée Lauder, Nike, and Procter & Gamble.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity Advances Share Buyback Program with Recent Repurchase
Dec 8, 2025

Essity has repurchased 190,572 Class B shares as part of its SEK 3bn buyback program, which is set to continue until the 2026 Annual General Meeting. This move, financed by cash flow from operations, aims to make share buybacks a recurring element of Essity’s capital allocation strategy, potentially impacting shareholder value positively.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity AB Announces Strategic Reorganization of Business Areas
Dec 2, 2025

Essity AB announced a reorganization of its business areas effective January 1, 2026, to enhance growth and achieve financial targets more swiftly. The new structure will consist of Health & Medical, Personal Care, Consumer Tissue, and Professional Hygiene, replacing the previous categories. This strategic change is expected to streamline operations and improve market focus, potentially impacting stakeholders positively by aligning the company’s offerings with market demands.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Essity AB Advances Share Buyback Program with Recent Repurchase
Dec 1, 2025

Essity AB announced the repurchase of 186,672 Class B shares as part of its SEK 3 billion buyback program, which is set to continue until the 2026 Annual General Meeting. This strategic move, financed by cash flow from current operations, aims to make share buybacks a recurring element of Essity’s capital allocation strategy, potentially enhancing shareholder value and market positioning.

The most recent analyst rating on ($SE:ESSITY.B) stock is a Buy with a SEK291.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 26, 2026